Literature DB >> 17712772

Lack of cross-hepatotoxicity between voriconazole and posaconazole.

Hong Foo, Thomas Gottlieb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712772     DOI: 10.1086/521174

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Lack of allergic cross-reactivity between fluconazole and voriconazole.

Authors:  Angie Pinto; Raymond C Chan
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

Review 2.  Risk factors for idiosyncratic drug-induced liver injury.

Authors:  Naga Chalasani; Einar Björnsson
Journal:  Gastroenterology       Date:  2010-04-12       Impact factor: 22.682

Review 3.  Antimicrobial guide to posterior segment infections.

Authors:  Tapan P Patel; David N Zacks; Vaidehi S Dedania
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-06       Impact factor: 3.117

4.  Hepatotoxicity of Antimycotics Used for Invasive Fungal Infections: In Vitro Results.

Authors:  Sandra Doß; Heike Potschka; Fanny Doß; Steffen Mitzner; Martin Sauer
Journal:  Biomed Res Int       Date:  2017-04-04       Impact factor: 3.411

Review 5.  Review of Pharmacologic Considerations in the Use of Azole Antifungals in Lung Transplant Recipients.

Authors:  Megan E Klatt; Gregory A Eschenauer
Journal:  J Fungi (Basel)       Date:  2021-01-22

Review 6.  Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?

Authors:  Gemma E Hayes; Lilyann Novak-Frazer
Journal:  J Fungi (Basel)       Date:  2016-06-07

7.  Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis.

Authors:  Javier Martínez-Casanova; Nuria Carballo; Sonia Luque; Luisa Sorli; Santiago Grau
Journal:  Infect Drug Resist       Date:  2018-03-05       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.